跳轉至內容
Merck
首頁法律產品許可證Roche Distribution Agreement

Roche Distribution Agreement

Roche Biochemical Reagents

On July 1, 2015 we signed an exclusive, global distribution agreement for Roche Biochemical Reagents. This agreement was then renewed for another five years in 2019.

Products covered by the agreement include:

  • Genomics - Products for DNA labeling and detection, restriction enzymes, molecular cloning kits, and conventional PCR applications
  • Cellular Analysis - Tissue dissociation reagents, transfection reagents and functional cell assays
  • Proteomics - Protease and phosphatase inhibitors, assay substrates, antibodies and protein detection and purification reagents.

Kapa Biosystems PCR and qPCR Reagents

On January 1, 2017 the global distribution agreement with Roche was expanded to include a complementary suite of high-performance, directed evolution PCR and qPCR enzyme products from Kapa Biosystems, a company acquired by Roche in 2015. This agreement does not include Kapa’s Next Generation Sequencing (NGS) portfolio, or the Kapa HiFi kits.

Download the Kapa Biosystems Distribution Agreement to learn more.

Select Roche Nucleic Acid Purification and qPCR Reagents

On August 1, 2017 the global distribution agreement with Roche was expanded to include the following product lines:

  • Select High Pure and Genopure Kits
  • Transcriptor Reagents
  • EagleTaq and FastStart Master Mixes (for non-LightCycler® Systems)
  • Universal ProbeLibrary Probes and Assays.

Download the Expansion Agreement Q&A to learn more.

登入以繼續

若要繼續閱讀,請登入或建立帳戶。

還沒有帳戶?

為便利客戶閱讀,此頁面中文以機器翻譯完成。雖然我們已盡力確保機器翻譯的準確性,但機器翻譯並非完美。如果您對機器翻譯的內容不滿意,請參考英文版本。